FDA psychedelics research funding information session

December 13, 2021 3:30 PM | Judy Pfeiffer (Administrator)

From the U.S. Food and Drug Administration:

The US Food and Drug Administration’s Controlled Substances Program is holding a virtual information session on research funding to improve scientific understanding of psychedelics. 

During the session, we will provide information about FDA’s recent activities regarding psychedelics, and we will share how the upcoming research funding opportunity fits into our work. We will also give a brief overview of the Controlled Substances Program, which aims to promote the public health by minimizing risks associated with problematic use of controlled substances while enabling appropriate access for medical use.

The session will take place on Friday, December 17th at 11.05 AM EST. RSVPs will be accepted to CDERCSP@fda.hhs.gov on a first-come, first-served basis no later than 12/15/21. If you are unable to attend but would like to learn more, please email CDERCSP@fda.hhs.gov to receive a recap email after the information session. 


The mission of the American Osteopathic Academy of Addiction Medicine is to improve the health of individuals and families burdened with the disease of addiction.

Powered by Wild Apricot Membership Software